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Abstract
In the endoplasmic reticulum, calreticulin acts as a chaperone and a Ca
2+-signalling protein. At the cell surface, it mediates
numerous important biological effects. The crystal structure of the human calreticulin globular domain was solved at 1.55 A ˚
resolution. Interactions of the flexible N-terminal extension with the edge of the lectin site are consistently observed,
revealing a hitherto unidentified peptide-binding site. A calreticulin molecular zipper, observed in all crystal lattices, could
further extend this site by creating a binding cavity lined by hydrophobic residues. These data thus provide a first structural
insight into the lectin-independent binding properties of calreticulin and suggest new working hypotheses, including that
of a multi-molecular mechanism.
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Introduction
Calreticulin (CRT) is an intriguing multi-compartmental
protein involved in many cellular processes with broad patho-
physiological implications [1,2]. In addition to its well-character-
ized function as a carbohydrate and non-native-peptide-recogniz-
ing chaperone and Ca
2+-signaling molecule in the endoplasmic
reticulum [3], CRT was shown to play a key role in the MHC class
I assembly pathway [4,5]. CRT also moves to the cell surface and
extracellular milieu, where it is involved in a variety of other
important functions, such as cell adhesion, migration and
proliferation, or wound healing [1,2]. Finally CRT was recently
proposed to be a surface ‘eat-me’ signal of dying cells, also
conserved in drosophila [6–8]. The molecular and structural
determinants involved in these various CRT properties still need
to be deciphered, except for the lectin binding site [9].
CRT and its membrane-bound homologue calnexin (CNX)
both comprise an extended proline-rich P-domain inserted
between N- and C-terminal domains, called N and C, the latter
bearing a highly charged extremity (Figure 1). The pioneering
crystallographic analysis of a large fragment from CNX has
revealed an extended P-domain inserted into a globular legume
lectin-like domain [10], but available structural data for CRT have
long been restricted to the NMR structure of its P-domain [11].
To gain further structural insights on this protein, we have solved
the X-ray structure of the human CRT globular domain. The
structure is compared to that of CNX [10] and of the lectin
domain of mouse CRT released very recently [9]. Two patches of
evolutionary conserved surface residues are described, emphasiz-
ing their atypical properties and functional roles. Careful analysis
of the crystal packing interactions reveals that the disordered N-
terminal extension binds to the edge of the lectin site and that an
intriguing CRT molecular zipper could provide a larger binding
platform. These observations provide a new structural basis for the
non-lectin chaperone activity of CRT.
Results and Discussion
Designing a CRT fragment suitable for X-ray
crystallography
Due to their flexible nature, the P-domain and the C-terminal
extension of CRT were expected to preclude crystallization of the
full-length protein. We therefore designed a truncated protein in
which the P-domain was replaced by a GSG linker and the C-
terminal residues 369–417 were deleted (Figure 1A). The P-
domain boundaries were deduced from the X-ray structure of
CNX and the NMR structure of the rat CRT P-domain [10,11].
These domain limits (residues 204–302) slightly differ from those
currently found in sequence databases (residues 197–308)
(Figure 1A). The size of the C-terminal deletion was more difficult
to predict. Several constructs were produced, and the fragment
ending at Lys368 gave the best results in terms of crystallization. A
similar construct, with the same C-terminal end, was used to solve
the X-ray structure of the mouse CRT lectin domain [9].
In keeping with previous observations [12], monomeric CRT
coexisted with higher molecular weight forms after the affinity
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17886Figure 1. Structure of the human CRT globular domain. (A) Representation of the linear structure of CRT and of the construct used in this
study. N, P, C, the discontinuous CRT segments as defined usually. Amino acid numbering is that of the unprocessed polypeptide. HAT, His-tag; fX cl.,
factor X cleavage site. (B) Two different views of the CRT globular domain structure. Regions from the N and C segments are colored light blue and
dark blue, respectively. The Ca
2+ ion is represented as a golden sphere. The approximate location of the P-domain insertion is indicated. (C) Structural
alignment of human CRT and dog CNX. The positions of ß-strands and a-helices are indicated. The N-terminal extension and the linker are shown in
pink. Grey italics show residues not defined in the structure. Residues aligned (2) or defining the common core of human CRT and rat CNX (+) are
indicated. Residues included in the conserved clusters 1 and 2 are labeled 1 (green) and 2 (red), respectively.
doi:10.1371/journal.pone.0017886.g001
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chromatography (see Methods). Mass spectrometry analysis of
the purified material yielded a value of 32,201 Da (predicted mass:
32,202 Da). The thermal stability of the recombinant domain was
determined using a thermofluor assay [13], yielding a relatively
low Tm value (40uC), consistent with other analyses [9,14]. As this
domain contains a Ca
2+-binding site, calcium was used throughout
the purification process. Crystallization of this fragment proved to
be successful (see Methods), allowing crystallographic analyses.
High-resolution structure of the human CRT globular
domain
The structure of the human CRT globular domain (Figure 1B)
was solved at a resolution of 1.55 A ˚ and refined to Rwork and Rfree
values of 0.176 and 0.190, respectively (Table 1). At such a
resolution, most of the residues are very clearly defined. Only
residues 203–204 and 302–303, on either side of the linker, and
the C-terminal Leu-Lys residues were not clearly seen in the
electron density. The two crystal forms obtained at different pH
(8.5–9.0 and 5.7–7.0) yielded similar structures, except for their N-
terminal extension.
Like its counterparts in CNX and mouse CRT, the human
CRT globular domain exhibits a jelly-roll fold assembled from two
anti-parallel ß-sheets, one convex and one concave. Remarkably,
the C domain inserts into the globular domain, providing the
central strands ß19 and ß20 of the ß-sandwich structure
(Figure 1B). The long C-terminal a3 helix is kinked at Thr346.
Subtle differences in this kink orientation induce a 1.5 A ˚
displacement at the end of a3 between different molecules of the
first crystal form. Interestingly, the free Cys163, mutated to Ser in
the mouse CRT globular domain, is not accessible in this
conformation, as it is buried between residues from strands ß7
and ß10. Otherwise, this structure is quite similar to that of mouse
CRT [9], with a r.m.s. deviation of only 0.4 A ˚ based on 242
superposed Ca positions. Likewise, the Ca
2+ ion is also
coordinated by 7 ligands contributed by the backbone carbonyls
of Gln26, Lys62 and Lys64, two water molecules, and both side-
chain carboxyl oxygens of Asp328.
The human CRT and dog CNX globular domains exhibit an
r.m.s. deviation of 1.6 A ˚ based on 213 superimposed Ca positions,
this value dropping to 0.77 A ˚ when considering a common core
defined by 142 Ca positions (see Figure 1C). Despite this overall
homology, these two structures differ in certain regions (Figures 1B,
1C). CRT lacks the N-terminal extension present in CNX, and
thus its N- and C-terminal ends lie on opposite faces of the
structure. Compared to CNX, the C-terminal helix of CRT is
prolonged by a large extension (residues 347–366). Two other a-
helical structures, a1 (residues 29–35) and a2 (residues 196–199)
are present in CRT. The loop before strand ß2, and those between
ß8 and ß9 are much shorter in CRT. Strand ß9 and the following
loop are slightly different in the two structures. Helix a1 observed
in CNX is absent in human CRT.
Two surface patches are common to CRT and CNX
Although CRT and CNX have common folds, most of their
surface-exposed side chains are different, with the striking
exception of two patches of residues. The most extended patch
is located on the concave ß-sheet surface (Figure 2A). From a
functional standpoint, this first cluster corresponds to the lectin site
of CRT and CNX, as identified by mutagenesis experiments and
recently deciphered by the X-ray structure of the mouse CRT
lectin domain complexed to a tetrasaccharide [9]. The most
conserved residues in this patch are Cys105 and Cys137 engaged
in a disulfide bridge and the nearby Gly107; Tyr109, Pro134 and
Asp135 in the middle of the patch; Lys111 and the neighboring
residues His145 and Ile147 on the edge. Less conserved residues
Trp319, Met131 and Tyr128 also contribute to the patch. This
cluster includes many charged residues that are mostly buried:
Lys111 (.75% buried), Asp135 (.60%), Asp317 (about 80%).
The central Tyr109 is also buried (80%), except for its hydroxyl
group that is always protonated at physiological pH because of its
high pKa value (.12).
A second smaller patch of conserved surface residues comprises
Asp166 (233 in CNX), His170 (237), Tyr172 (239), Asp187 (254)
and Trp347 (456) (Figure 2B). These side-chains are superimposed
in CRT and CNX despite significant differences in the
conformation of the preceding loop (Figure 2B). In the central
Asp/His/Asp triad, the His residue is wedged in-between the two
charged Asp side chains at H-bonding distances (Figure 2B). This
atypical environment had not been described so far. The strong
sequence conservation of these residues (Figures S1, S2) further
suggests that they may have functional implications. In accord
with this hypothesis, the His170Ala mutation was shown to
dramatically impair the CRT chaperone function in vivo [15]. It
was initially proposed that this effect could be due to a
conformational change that would extend up to the lectin site
[15]. However, this site is about 20 A ˚ away from His170, on the
opposite side of the beta-barrel (Figure S3). How this mutation
could alter the lectin site at such a distance is therefore unclear.
The hypothesis of a large conformational change was based in part
on the observation that the His170Ala mutation induces changes
in Trp fluorescence and circular dichroism [15]. However, the
circular dichroism spectra of the wild-type and mutant proteins
had similar shapes, and the mutant was produced in vivo at the
same level as the wild-type species [15]. In the X-ray structure,
Trp347 lies in close proximity to Asp187 (3.2 A ˚, Figure 2B). The
Table 1. Data collection and refinement statistics.
1
st crystal form 2
nd crystal form
PDB code 3POS 3POW
Data collection
ESRF Beamline Id29 Id23-eh2
Space group P212121 P212121
Cell (a, b, c) A ˚ 42.2, 91.1, 194.0 42.9, 70.4, 91.8
Resolution range high/low (A ˚) 1.65–20 1.55–10.0
Last resolution shell high/low (A ˚) 1.65–1.7 1.55–1.59
Observed reflections
a 1416077 (20909) 187458 (14576)
Unique reflections
a 88382 (6434) 39833 (3013)
Redundancy
a 16 (3.2) 4.7 (4.8)
Completeness (%)
a 96.8 (83.0) 96.8 (99.9)
I/SigI
a 18.8 (2.4) 15.2 (3.0)
Rsym (%)
a 11.7 (45.4) 7.0 (53.5)
Refinement
Resolution range high/low A ˚ 1.65–19.9 1.55–10.0
Last resolution shell high/low (A ˚) 1.65–1.69 1.55–1.59
Rwork/Rfree (%)
a,b 17.0/20.7 (21.2/22.2) 17.6/19.0 (24.4/26.2)
R.m.s.d. Bound/Angle (A ˚/u) 0.01/1.07 0.009/1.16
Mean B factor (A ˚2) 19.3 16.8
aValues in parentheses are for outermost shell.
b5% of the structure factors were isolated to monitor Rfree.
doi:10.1371/journal.pone.0017886.t001
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and charge of Asp187, altering in turn the spectral properties of
the neighboring Trp347. Therefore, even a local destabilization of
the DHD cluster is likely to alter the Trp fluorescence and circular
dichroism spectrum of CRT. Thus, although this question
warrants further experimental investigation, we believe that this
second patch of residues could also support a functional role, in
light of its striking structural and sequence conservation and in
agreement with previous in vivo data.
A peptide-binding site on the edge of the lectin site
CNX and CRT also act as chaperones on non-glycosylated
substrates [3,16] and the CNX globular domain has been shown
to bind peptides through a hitherto unidentified site that has been
proposed to be distinct from the lectin site [17]. In this respect, our
crystallographic analyses of the human CRT globular domain
reveal interesting polypeptide-binding properties. The unfolded N-
terminal extension fused to CRT for purification purposes is
indeed consistently found to interact with the edge of the lectin
site, and the quality of the electron density shows that this
interaction is specific. To achieve such an interaction, this
extension adopts a wide range of conformations, with some
disordered parts, emphasizing its flexible nature (Figure 3A). No
crystal was obtained when the preceding HAT tag was present. No
interaction was observed in the crystal packing between this edge
of the lectin site and properly folded segments of the CRT
molecules. Two different modes of interaction were observed. The
first mode involves H-bonding between Asp135 and the hydroxyl
group and peptide bond nitrogen of Ser13. Three such
interactions were observed in the first crystal form (Figure 3B).
A distinct interaction mode, involving an ionic bond between
Asp317 and Arg17, was observed in the second crystal form
(Figure 3C). Interestingly, inspection of the carbohydrate-free
crystal form (pdb code 3O0V) obtained by Kozlov et al (2010) also
reveals an interaction between the N-terminal Gly-Ser-Met
extension and the edge of the lectin site. Moreover, Ser16 and
Met17 of the mouse CRT construct are strikingly superposed to
the corresponding residues Ser13 and Arg17 of our human CRT
construct, as observed in the first and second crystal forms,
respectively (Figure 3D). Altogether, these independent observa-
tions convincingly map a peptide-binding site comprising Phe74,
Trp319, Cys105, Cys137, and Asp135 (Figures 3 and S3). This site
mainly contributes hydrophobic contacts, except for the polar
interactions described above. Phe46, at the bottom of the Met17
binding pocket, also contributes to the hydrophobic environment.
Additional contacts provided by Met131, Asp317 (Figure 3B),
Gly106 (Figure 3C), or Gly124 (Figure 3D) are also observed but
seem secondary to the main interaction site. Thus, we may have
identified two sub-sites of the hitherto unknown peptide-binding
site of CRT. This site overlaps the carbohydrate-binding site of the
homologous mouse CRT lectin domain recently identified by X-
ray analysis [9], suggesting that different types of ligands can bind
Figure 2. Surface patches common to CRT and CNX. (A) The more extended patch, cluster 1, corresponding to the identified lectin site [9]. (B)
The smaller cluster 2. CRT and CNX structures are in light blue and green, respectively. Labels correspond to CRT residues, and red labels indicate the
most conserved ones. Hydrogen bonds are represented by dotted red lines. The two patches are displayed using stereograms.
doi:10.1371/journal.pone.0017886.g002
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involved in all the peptide-binding interactions depicted here, was
shown to be essential to the CRT in vivo chaperone activity and to
its in vitro ability to prevent thermal aggregation of MDH, a non
glycosylated substrate [18]. The same effect was also true, to a
lesser extent, for the Cys105–Cys137 disulfide bond [18], which is
also at the edge of this common carbohydrate/peptide-binding
area. On the other hand, several mutations have been shown to
suppress the lectin activity of CRT or CNX without affecting other
carbohydrate-independent functions, such as suppression of the
aggregation of thermally denatured non-glycosylated proteins
[17,19], in vitro peptide-binding [17], and chaperoning of class I
histocompatibility molecules [20]. These mutations map a
particular area of the lectin domain, the one that specifically
recognizes the glucose unit (Figure S3). The corresponding
residues include Y109, K111, Y128 and D317 of CRT [19,20],
as well as Y166, M169, I184 of CNX, which are homologous to
Y128, M131 and I147 in CRT [17]. Interestingly, these residues
are located on the side opposite to the peptide-binding site
described above (Figure S3), and their mutations into alanine will
not affect the peptide-binding property. Thus, even though the
proposed peptide-binding site lies on the edge of the lectin site, in
an area where carbohydrate-binding also occurs, this location is
fully compatible with previous mutagenesis data.
An intriguing CRT molecular zipper
Most of the residues in the proposed peptide-binding site are
common to the CRT and CNX families, but Phe74 is specific to
CRT. It is conserved in most of the CRT sequences, except for a
group of plant CRTs (Figure S4). Intriguingly, the preceding
CRT-specific 69–73 SQDAR segment largely contributes to a
crystal packing interaction omnipresent in the crystal forms
obtained so far. Ionic bonds between Asp71 and Arg162, and
between Arg73 and Glu167 are central to this interaction. These
are complemented by hydrophobic contacts between Val50 and
Pro139, and by H-bonding interactions bridging the main-chain
atoms of Ser69 and Asp71 to the tip of Lys142 and Asp165 side-
chains, respectively. These mainly polar interactions thus repre-
sent the most favorable CRT/CRT interface, at least in the
crystalline state, since they have been observed three times in the
first crystal form, and once in the second form. We have also
checked that these interactions occur consistently in the crystal
packing of the mouse CRT lectin domain (pdb codes 3O0V,
3O0W, 3O0X), thus providing four additional observations.
Finally, these interactions are observed over a wide range of pH
(5.5–9.0), whereas the interactions mediated by the nearby His42
and His123 change polarity in this pH range, thus giving rise to
two different crystal forms in our study.
Further analysis of this set of conserved interactions reveals
intriguing properties. First, a molecular zipper is formed when
these interactions are applied on both sides of the CRT domain
(residues 71–73 and 162–167) (Figure 4A). It is composed of two
lines of molecules with inverted orientations, one with the ligand-
binding site up, the other down (Figure 4A), the long C-terminal
helices providing both a flat basis and a flap (Figure 4C). Linear
assemblies of CRT molecules are also seen on electron
micrographs (Figure 4B). A close inspection of the area of the
peptide-binding site reveals that it is next to a cavity formed by the
3 neighboring molecules (Figure 4D). Moreover, Trp319 comes
across this cavity in relative proximity (10 A ˚) to the Asp-His-Asp
triad of the neighboring molecule (Figure 4E), despite the fact that
these elements lie on opposite sides of the same CRT molecule
(Figure S3). Given that both His170 and Trp319 were shown to be
essential for the in vivo chaperone activity of CRT [15,18], this
raises the intriguing question of a possible functional relevance of
such a proximity. In addition, fully or partially exposed
hydrophobic side-chains line the cavity in this area (Figure 4E),
which further suggests that this may complement the above-
described site for the binding of unfolded peptides. The cavity may
complement as well the lectin site, introducing binding properties
specific to CRT and distinct from those of CNX. Finally, it should
be stressed that this set of interactions can likely be also achieved in
full-length CRT, the C-terminal extension and the P-domain
being located on two lateral sides of the array of molecules
(Figures 4C, 4D).
Conclusion
This high-resolution structure of the globular domain of human
CRT provides a very accurate model for future investigations.
Similar domain limits are observed for the human and mouse
CRT globular domains [9], which both include the 18–202
segment from the N domain and the 303–366 segment from the C
domain. Consistent structural domain limits must be used when
dissecting CRT to locate functional units and binding sites.
Moreover, several independent serendipitous observations lead to
the first description of unfolded protein segments bound to CRT,
on the outer edge of the lectin site. Further investigations of the
binding specificity of this area might be possible by specifically
designing the sequence of the N-terminal extension of CRT. On
the edge of this peptide-binding site, the SQDAR segment, which
is specifically found in CRT sequences, exhibits a strong
propensity for interaction, at least with other CRT molecules.
This raises the possibility for CRT to generate larger peptide-
binding platforms. The molecular zipper formed in the crystals
through the SQDAR-mediated interactions looks biologically
relevant in several ways, especially if one considers that CRT is
often associated to membrane surfaces, a situation that possibly
stabilizes such elongated, thin and flat oligomers. As such, these
observations provide a structural basis to reconsider in part the
chaperone and other CRT functions as multi-molecular processes.
Materials and Methods
Protein expression and purification
All expression plasmids were derived from plasmid pHFX-CRT,
containing the cDNA encoding full-length human CRT (MRC Gene
Service, Cambridge, UK) fused at its N-terminus to an HAT tag
followed by a factor X cleavage site. The P-domain (residues 204–
302) was replaced by a GSG linker, as described elsewhere [21], and
truncation of the C-terminal segment after residue 368 was obtained
using the primer 59-GGACAAACAGGACGAGGAGCA-
GAGGCTTAAGTAGTAAGCTTGCGGCCGCACTCGAGC-39
and reverse. Transformed Rosetta 2(DE3) cells (Novagen) were
optimally grown at 37uC and protein production was induced by
Figure 3. The N-terminal extension of CRT interacts with the edge of the lectin site. (A) Superposed views of the N-terminal extensions. (B)
The interaction mode observed in the first crystal form. (C) The interaction mode observed in the second crystal form. (D) Superposition of the
interacting regions of human CRT and the corresponding region of mouse CRT. Labels correspond to interacting residues of human CRT in (B) and (C),
and to mouse CRT in (D). Hydrogen bonds and ionic interactions are represented by dotted red lines. The blue dotted lines in (A) represent
disordered parts. F1, F2: crystal forms 1 and 2; m: mouse CRT. All items are displayed as stereograms.
doi:10.1371/journal.pone.0017886.g003
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HCl, 0.3 M NaCl, 5 mM CaCl2,1 0m Mi m i d a z o l e ,p H7 . 5 ,u s i n g
the FASTPrep matrix(MP Biomedicals).Purification was performed
in the same buffer by affinity chromatography on a Ni
2+-Sepharose
resin(HiTrap
TM, Amersham).Fractionscontaining the CRT domain
were further purified on a S75 16/60 prep grade gel filtration column
(GE/Amersham). Fractions containing pure monomeric CRT, as
checked by non-denaturing SDS-PAGE, were concentrated to
12 mg/mL. Control of the sample thermostability was performed
at the EMBL htxlab facility using thermal-shift assays.
Crystallization
Initial crystallization conditions were determined using the
EMBL htxlab facility and commercial screens (QIAGEN),
allowing generation of needle-like crystals. Optimal conditions
were reproduced manually using the vapor diffusion method, at
4uC. Crystal form I was obtained using a reservoir solution
containing 30% polyethylene glycol (PEG) 4000, 0.1–0.2 M
sodium acetate, 0.1 M Tris-HCl, pH 8.5 or 9.0. Crystal form II
was obtained using 30% PEG 4000, 0.2 M ammonium acetate,
10 mM magnesium acetate, and either 0.05 M MES, pH 5.7 or
6.0, or 0.05 M HEPES, pH 7.0.
X-ray structure determination
The initial best diffracting crystal had a long needle-like shape
(.250 mm) that allowed us to translate it to record several data sets
at different exposure times. Data processing and scaling were
performed using XDS [22]. The three most coherent data sets
could be merged to obtain a highly accurate and redundant
unique data set at 1.7 A ˚ resolution. Data collection statistics are
listed in Table 1. In this first crystal form, the space group is
P212121, with cell dimensions a=42.4 A ˚, b=91.5 A ˚, c=194.8 A ˚.
The solvent content is about 40%, and the asymmetric unit
contains 3 molecules. The structure was solved by iterative
molecular replacements. The core structure comprising the main
secondary structure elements of the CNX lectin domain [10] was
used as a starting search model. After careful inspection of the
electron density, a smaller search model was defined, restricted to
the 130 best fitting residues. The correct molecular replacement
solution was obtained  using this second search model on the
CaspR website ( igs.cnrs-mrs.fr/Caspr2/index). Although the
initial R-factor was high after the AMORE step [23], it dropped to
0.45 after 200 minimization steps using CNS refinement [24] at
3A ˚ resolution. That this solution was valid was confirmed by the
observation of several residue substitutions in the electron density
map, convergence of the CNS refinement minimizations steps
using non-crystallographic restraints at 1.6 A ˚ resolution, and
improved iterative automatic reconstruction of this model using
Figure 4. The CRT molecular zipper. (A) Schematic representation
of the zipper. A red circle indicates the position of the binding site.
Small circles locate the relative position of the SQDAR segment (pink)
and its interacting residues in the neighboring molecule (yellow). The C-
terminal helices are drawn in dark blue. (B) Negative-staining electron
micrograph of the CRT construct. (C, D) Two orthogonal side- and top-
views (the latter framed in A) of the interactions between CRT
molecules defining the molecular zipper as seen in the crystal lattice.
Residues involved in hydrogen and ionic bonds are shown in pink
(segment SQDAR) and yellow. P marks the insertion position of the
missing P domain. (E) Detailed view of the pocket lining the binding site
as framed in (D). Exposed hydrophobic residues lining the pocket are in
yellow; charged residues exposing a large hydrophobic surface
(.65 A ˚2), forming a secondary shell, are in pale green; Residues shown
by mutation to be essential for the chaperone function of CRT are in red
(W319) and orange (H170).
doi:10.1371/journal.pone.0017886.g004
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www.the ARP/wARP procedure [25]. Iterative reconstruction of the
model was carried out using O [26], CNS, and the ARP/wARP
procedure until recovery of most of the residues. Standard iterative
rounds of manual building and refinement steps were finally
carried out using BUSTER and Coot [27,28].
Crystal form II diffracted to 1.55 A ˚. The space group is
P212121, with cell dimensions a=42.9 A ˚, b=70.4 A ˚, c=91.8 A ˚.
The solvent content is about 45%, with a single molecule per
asymmetric unit. The structure was easily solved using the Phaser
molecular replacement software [29], using the structure of one
molecule of crystal form I as a search model.
Structure analysis
Two clusters of conserved surface residues were initially
identified by visual inspection of the superimposed CNX and
CRT structures. Comparison of the crystal contacts in the two
crystal forms obtained in this study also revealed a CRT segment
that is involved in the same crystal packing interactions.
The sequence conservation of the residues belonging to these
particular clusters and segment was then carefully analyzed. For
this purpose, several redundant tools have been used to analyze
the degree of sequence conservation in the CRT/CNX family:
CONSURF [30] and several other multiple sequence alignments
generated on the PipeAlign website ([31], http://igbmc.u-strasbg.
fr/PipeAlign) were used. Buried acidic and basic groups have long
been known to be more particularly present at functionally
important sites. Detection of such buried charged residues and
prediction of their pKa value was performed using the ProPKA
web server (http://propka.ki.ku.dk) [32].
Supporting Information
Figure S1 Sequence alignments of surface residues of
cluster 2. This sequence alignment shows how the residues
displayed in Figure 2B (highlighted in yellow) are strongly
conserved in the CRT/CNX sequence family. More detailed
information about the sequence names is provided in Figure S2.
(PDF)
Figure S2 Description of the set of sequences of the
CRT/CNX family. The following information about the
sequence names is indicated: main protein name (when defined),
source and alignment score of the whole sequence to the human
globular domain sequence. The sequences have been automati-
cally assigned to several groups using the pipealign procedure [30].
In the alignments, the sequence names directly coming from the
Swissprot database have the SW prefix; the other protein
sequences, translated from the gene, have the SPT prefix.
(PDF)
Figure S3 Relative locations of the glucose-binding site,
the peptide-binding site, cluster 2 and the main
mutations affecting the in vivo chaperone properties.
A. Zoom on the lectin site. B. The lectin site and cluster 2 are
located on two opposite sides of the beta-barrel. Mutations
affecting only the lectin activity, which line the glucose-binding site
(GBS) are colored magenta in A and green in B. The proposed
peptide-binding site is colored orange in A, red and yellow in B.
The red and orange residues in B highlight the mutations affecting
the in vivo chaperone properties.
(PDF)
Figure S4 Sequence alignments of the SQDAR 69–73
segment. This sequence alignment shows how the residues
highlighted in yellow are well conserved in the CRT groups 1 and
2; less conserved in groups 3 and 4; and not conserved in the group
5. The following F74 (green) is found in most of the CRT-like
sequences, except for the plant group 4. It is not present in the
CNX-like group 5 sequences. Details corresponding to the
sequence names are given in Figure S2.
(PDF)
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